Evidence map›Paper›PMID 30848001›Full record

Observational studyJournal of cardiovascular electrophysiology2019

Silent cerebral lesions and cognitive function after pulmonary vein isolation with an irrigated gold-tip catheter: REDUCE-TE Pilot study.

Boris Schmidt, Gábor Széplaki, Bela Merkely, Josef Kautzner, Vincent van Driel, Felix Bourier, Malte Kuniss, Alan Bulava, Georg Nölker, Muchtiar Khan and 5 more

Registry-linked trialOpen access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of cardiovascular electrophysiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04408716 (Risk of Asymptomatic Cerebral Embolism During Atrial Fibrillation Ablation Using Smart Touch SF Catheter With Ablation Index Guided High-power Short-duration Strategy Versus Smart Touch Catheter With Standard Settings Evaluated by High-resolution Diffusion-weighted Magnetic Resonance Imaging Technique), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04408716 nacompletednot on this mapstarted 2020, after this paper: background citation

Risk of Asymptomatic Cerebral Embolism During Atrial Fibrillation Ablation Using Smart Touch SF Catheter With Ablation Index Guided High-power Short-duration Strategy Versus Smart Touch Catheter With Standard Settings Evaluated by High-resolution Diffusion-weighted Magnetic Resonance Imaging Technique (REDUCE-IT Study)

TypeinterventionalSponsorThe Second Affiliated Hospital of Chongqing Medical UniversityRan2020 to 2021Enrolled100ConditionsAtrial FibrillationArmsAblation Index Guided High-Power Short-Duration Strategy, Standard Radiofrequency Ablation Technique
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Microembolizations in the arterial cerebral circulation during atrial fibrillation ablation: cryoballoon technique advantages and neurocognitive safety-results of a prospective observational study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Observational
  4. Incidence and predictors of stroke and silent cerebral embolism following very high-power short-duration atrial fibrillation ablation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  5. Article
  6. Impact of the ablation technique on release of the neuronal injury marker S100B during pulmonary vein isolation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2020
    Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 13 institutions in 5 countries.

Boris SchmidtCardioangiologisches Centrum Bethanien, Frankfurt, Germany.ORCID 0000-0001-5347-9906
Gábor SzéplakiSemmelweis University, Budapest, Hungary.
Bela MerkelySemmelweis University, Budapest, Hungary.
Josef KautznerIKEM, Prague, Czech Republic.
Vincent van DrielHaga Ziekenhuis, Den Haag, The Netherlands.
Felix BourierDeutsches Herzzentrum, München, Germany.
Malte KunissKerckhoff Klinik, Bad Nauheim, Germany.
Alan BulavaFaculty of Health and Social Sciences, Ceske Budejovice Hospital, University of South Bohemia, Budejovice, Czech Republic.
Georg NölkerKatharinen Hospital, Unna, Germany.
Muchtiar KhanOnze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
Thorsten LewalterPeter Osypka Heart Center, Munich, Germany.
Norbert KleinKlinikum St Georg, Leipzig, Germany.
Beate WenzelBiotronik SE & Co KG, Berlin, Germany.
Julian Kr ChunCardioangiologisches Centrum Bethanien, Frankfurt, Germany.
Dipen ShahHôpitaux Universitaires de Genève, Geneva, Switzerland.ORCID 0000-0001-6839-2192
Cardiovascular Center Bethanien · DESemmelweis University · HUBiotronik (Germany) · DEDeutsches Herzzentrum der Charité · DEHaga Hospital · NLHôpital Beau-Séjour · CHInstitute of Clinical and Experimental Medicine · CZKatharinenhospital · DEKerckhoff Klinik · DEKlinikum St. Georg · DEOLVG · NLOsypka (Germany) · DEUniversity of South Bohemia in České Budějovice · CZ

Funding

BiotronikBiotronik SE & Co
6 · The paper itself

Abstract

introductionStroke is one of the most feared complications during catheter ablation of atrial fibrillation (AF). While symptomatic thromboembolic events are rare, magnetic resonance imaging (MRI) may identify asymptomatic (ie, silent) cerebral lesions (SCLs) following pulmonary vein isolation (PVI) procedures. METHODS AND

resultsThe REDUCE-TE Pilot was a prospective multicenter, single-arm observational study investigating the incidence of SCL in patients with symptomatic paroxysmal AF undergoing PVI with a novel gold-tip, externally irrigated ablation catheter. After ablation, cerebral diffusion-weighted MRI and a postablation follow-up were performed at 1 to 3 days after the ablation procedure. A neurocognitive test was done before and after ablation. The primary study endpoint was the occurrence of one or more new SCLs. Secondary study endpoints included neurocognitive status, procedural success rate, and periprocedural complications including symptomatic thromboembolic events. A total of 104 patients were enrolled (69% male, mean age: 61.5 ± 9.7 years, mean CHA

conclusionsAblation of AF using a novel gold-tip, externally irrigated ablation catheter, resulted in SCLs in approximately one out of 10 patients without a measurable effect on neurocognitive function.

Indexed as

Cardiac CathetersCognitionGoldAction PotentialsAgedAsymptomatic DiseasesAtrial FibrillationCatheter AblationDiffusion Magnetic Resonance ImagingEquipment DesignFemaleGermanyHeart RateHumansIncidenceIntracranial EmbolismGoldablationatrial fibrillationcognitive functiongold-tip catheterirrigated catheterpulmonary vein isolationsilent cerebral embolism

Identifiers

PMID30848001
PMCPMC6849824
OpenAlexW2920850633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.